Detection of mRNAs of GA733 genes by RT-PCR in exfoliated cells of pleural and peritoneal effusions and its clinical values

Internal Medicine

Volumn 46, Issue 18, 2007, Pages 1489-1494

  Zhang, Kun He ^a   Cao, Feng ^b   Fu, Qu Bo ^b   Zhu, Jin Quan ^a   Chen, Jiang ^a   Lv, Nong Hua ^a  

^a NANCHANG UNIVERSITY   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

Molecular diagnosis; Neoplasm metastasis; Serous cavity effusions

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; GA 733 1 PROTEIN; MESSENGER RNA; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIGENE FAMILY; PERITONEAL FLUID; PERITONEUM EXUDATE; PLEURA EFFUSION; PLEURA FLUID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ASCITIC FLUID; CELL ADHESION MOLECULES; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 34948849854     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0199     Document Type: Article

References (23)

1. Oyafuso MS, Longatto Filho A, Bortolan J, Rahal P, Bisi H, Lombardo V. Cytological diagnosis of serous effusions in a cancer hospital in Brazil. Pathologica 88: 128-131, 1996.
2. Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 54: 1-9, 2006.
3. de Bree E, Theodoropoulos PA, Rosing H, et al. Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside. Cancer Treat Rev 32: 471-482, 2006.
4. Yamaguchi Y, Ohshita A, Kawabuchi Y, et al. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment. Int J Oncol 24: 959-966, 2004.
5. He DN, Zhu HS, Zhang KH, et al. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions. World J Gastroeenterol 10: 2406-2408, 2004.
6. Mohanty SK, Dey P. Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 79: 569-574, 2003.
7. Wu XZ, Fu YB, Zhang ZH, Huang XX, Wu GP, Zhou YC. Cytology examination of 702 patients with malignant serous cavity effusion. Zhongguo Yike Daxue Xuebao 29: 385-386, 2000 (in Chinese, Abstract in English).
8. Linnenbach AJ, Seng BA, Wu S, et al. Retroposition in a family of carcinoma-associated antigen genes. Mol Cell Biol 13: 1507-1515, 1993.
9. Winter MJ, Nagtegaal ID, van Krieken JH, Litvinov SV. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163: 2139-2148, 2003.
10. Ripani E, Sacchetti A, Corda D, Alberti S. Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 76: 671-676, 1998.
11. Sakaguchi M, Virmani AK, Ashfaq R, et al. Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions. Br J Cancer 79: 416-422, 1999.
12. Nagel H, Werner C, Hemmerlein B. Real-time reverse transcription polymerase chain reaction assay for GA733-2 mRNA in the detection of metastatic carcinoma cells in serous effusions. Am J Clin Pathol 120: 888-901, 2003.
13. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindan J. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 93: 68-72, 2001.
14. Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn Cytopathol 32: 151-155, 2005.
15. Zhang KH, Wu XP, Lu NH, Zhu JQ. The image scanning, processing and preserving of polyacrylamide gel electrophoresis results based on computer. Yi Xue Xin Xi 14: 261-262, 2001 (in Chinese).
16. Passebosc-Faure K, Li G, Lambert C, et al. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions. Clin Cancer Res 11: 6862-6867, 2005.
17. Herlyn D, Herlyn M, Ross AH, Ernst C, Atkinson B, Koprowski H. Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J Immunol Methods 73: 157-167, 1984.
18. Ross AH, Herlyn D, Iliopoulos D, Koprowski H. Isolation and characterization of a carcinoma-associated antigen. Biochem Biophys Res Commun 135: 297-303, 1986.
19. Went PT, Lugli A, Meier S, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 35: 122-128, 2004.
20. Xie X, Wang CY, Cao YX, et al. Expression pattern of epithelial cell adhesion molecule on normal and malignant colon tissues. World J Gastroenterol 11: 344-347, 2005.
21. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23: 5748-5758, 2004.
22. Gommans WM, van Eert SJ, McLaughlin PM, et al. The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context. Cancer Gene Ther 13: 150-158, 2006.
23. Szala S, Froehlich M, Scollon M, et al. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci USA 87: 3542-3546, 1990.